10x Genomics, Inc.

TXG

$15.70

Name : 10x Genomics, Inc.

Sector : Healthcare

Industry: Health Information Services

Mark. Cap: $1,986,882,816.00

EPSttm : -0.63

10x Genomics, Inc.

$15.70

1.20%

$0.19

Float Short %

13.39

Margin Of Safety %

-37

Put/Call OI Ratio

0.26

EPS Next Q Diff

0.04

EPS Last/This Y

1.47

EPS This/Next Y

-0.36

Price

15.7

Target Price

16.33

Analyst Recom

2.21

Performance Q

17.08

Relative Volume

0.85

Beta

2.13

Ticker: TXG

21 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-10-20	TXG	13.14	0.18	0.02	11419
2025-10-21	TXG	13.04	0.15	0.04	13573
2025-10-22	TXG	12.27	0.16	4.63	13280
2025-10-23	TXG	13.39	0.25	0.16	14459
2025-10-24	TXG	13.77	0.25	0.03	14463
2025-10-27	TXG	13.6	0.25	0.09	14569
2025-10-28	TXG	13.38	0.24	0.20	15062
2025-10-29	TXG	12.86	0.24	3.88	15087
2025-10-30	TXG	12.43	0.31	1.94	16210
2025-10-31	TXG	13.63	0.34	1.77	16902
2025-11-03	TXG	13.69	0.29	0.49	15889
2025-11-04	TXG	13.36	0.29	1.86	15998
2025-11-05	TXG	13.5	0.31	6.89	16416
2025-11-06	TXG	13	0.35	2.37	16900
2025-11-07	TXG	15.24	0.43	1.52	18165
2025-11-10	TXG	17.08	0.31	0.03	16234
2025-11-11	TXG	16.6	0.30	0.07	16781
2025-11-12	TXG	16.7	0.29	0.19	17084
2025-11-13	TXG	16.36	0.29	5.05	17212
2025-11-14	TXG	15.88	0.27	0.07	16966
2025-11-17	TXG	15.7	0.26	0.01	17453
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

21 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-10-20	TXG	13.14	-358.4	-114.9	0.09
2025-10-21	TXG	13.03	-358.4	-88.3	0.09
2025-10-22	TXG	12.26	-358.4	-77.3	0.09
2025-10-23	TXG	13.37	-358.4	-110.2	0.09
2025-10-24	TXG	13.78	-358.4	-96.9	0.09
2025-10-27	TXG	13.60	-358.4	-87.6	0.09
2025-10-28	TXG	13.34	-358.4	-86.1	0.09
2025-10-29	TXG	12.90	-358.4	-82.9	0.09
2025-10-30	TXG	12.44	-358.4	-82.3	0.09
2025-10-31	TXG	13.64	-358.4	-111.4	0.09
2025-11-03	TXG	13.71	-358.4	-91.3	0.09
2025-11-04	TXG	13.37	-358.4	-84.9	0.09
2025-11-05	TXG	13.51	-358.4	-92.4	0.09
2025-11-06	TXG	12.99	-358.4	-82.1	0.09
2025-11-07	TXG	15.25	-358.4	-128.1	0.09
2025-11-10	TXG	17.08	-358.4	-119.7	0.09
2025-11-11	TXG	16.59	-25.4	-18.9	-0.49
2025-11-12	TXG	16.70	55.8	-11.5	-0.05
2025-11-13	TXG	16.36	55.8	-6.5	-0.05
2025-11-14	TXG	15.88	55.8	-4.9	-0.05
2025-11-17	TXG	15.70	55.8	-8.1	-0.05
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-10-20	TXG	-0.42	4.61	11.38
2025-10-21	TXG	-0.42	4.61	11.38
2025-10-22	TXG	-0.42	4.61	11.38
2025-10-23	TXG	-0.42	4.61	11.38
2025-10-24	TXG	-0.42	4.61	11.38
2025-10-27	TXG	-0.42	4.54	11.36
2025-10-28	TXG	-0.42	4.54	11.36
2025-10-29	TXG	-0.42	4.54	11.36
2025-10-30	TXG	-0.42	4.54	11.36
2025-10-31	TXG	-0.42	4.54	11.36
2025-11-03	TXG	-0.42	3.84	11.36
2025-11-04	TXG	-0.42	3.84	11.36
2025-11-05	TXG	-0.42	3.84	11.36
2025-11-06	TXG	-0.42	3.84	11.36
2025-11-07	TXG	-0.42	3.84	11.36
2025-11-10	TXG	-0.42	-1.25	11.36
2025-11-11	TXG	-0.42	-1.25	11.36
2025-11-12	TXG	-0.42	-1.25	13.60
2025-11-13	TXG	-0.42	-1.25	13.36
2025-11-14	TXG	-0.42	-1.25	13.36
2025-11-17	TXG	-0.42	0.24	13.39
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

-0.22

Avg. EPS Est. Current Quarter

-0.06

Avg. EPS Est. Next Quarter

-0.18

Insider Transactions

-0.42

Institutional Transactions

0.24

Beta

2.13

Average Sales Estimate Current Quarter

155

Average Sales Estimate Next Quarter

143

Fair Value

9.89

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

92.5

Max Drawdown 5-Year %

-96.5

Target Price

16.33

P/E

Forward P/E

PEG

P/S

3.1

P/B

2.53

P/Free Cash Flow

27.21

EPS

-0.62

Average EPS Est. Cur. Y

-0.05

EPS Next Y. (Est.)

-0.41

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-11.89

Relative Volume

0.85

Return on Equity vs Sector %

-36.7

Return on Equity vs Industry %

-24.9

EPS 1 7Days Diff

-0.1

EPS 1 30Days Diff

-0.13

EBIT Estimation

-8.1

10x Genomics, Inc.

Sector: Healthcare

Industry: Health Information Services

Employees: 1306

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the Americas, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers Chromium platform that enables analysis of individual biological components, as well as includes microfluidic chips and related consumables, Chromium X Series, and Chromium instruments; Visium platform includes Spatial Gene Expression, HD Spatial Gene Expression, and Spatial Gene and Protein Expression assays, as well as the Visium CytAssist, an instrument designed to simplify and optimize the Visium solution workflow by facilitating the transfer of transcriptomic analytes from standard glass slides to Visium slides; and Xenium Analyzer instrument enables researchers to detect and preserve the cellular location of hundreds of RNA targets directly in a fresh frozen or FFPE tissue section. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.

stock quote shares TXG – 10x Genomics, Inc. Stock Price stock today

news today TXG – 10x Genomics, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch TXG – 10x Genomics, Inc. yahoo finance google finance

stock history TXG – 10x Genomics, Inc. invest stock market

stock prices TXG premarket after hours

ticker TXG fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: TXG

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y